WEST PALM BEACH, Fla, April 19, 2018 -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, today announces that it expects to file its full year audited financial statements for 2017 (on Form 10-K) and accompanying press release after market close on Monday April 23, 2018.
“We had previously disclosed our expectation to file this information on Tuesday April 17, 2018 but completion of our audited financial statements has taken a few days longer than expected, caused mainly by the addition of our new Hospital sector business and separation of discontinued businesses,” stated Seamus Lagan, President and Chief Executive Officer. “We look forward to disclosing our results and believe they reflect the progress we have made building our business through 2017.”
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
[email protected]
# # #


Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 



